Ralph K Akyea1, Yana Vinogradova1, Nadeem Qureshi1, Riyaz S Patel2,3, Evangelos Kontopantelis4,5, George Ntaios6, Folkert W Asselbergs7, Joe Kai1, Stephen F Weng1. 1. Primary Care Stratified Medicine, Division of Primary Care, University of Nottingham, Nottingham, United Kingdom (R.K.A., Y.V., N.Q., J.K., S.F.W.). 2. Institute of Cardiovascular Science, Faculty of Population Health Sciences (R.S.P., F.W.A.), University College London. 3. Health Data Research UK, Institute of Health Informatics (R.S.P., F.W.A.), University College London. 4. Division of Population Health, Health Services Research and Primary Care (E.K.), School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), The University of Manchester, United Kingdom. 5. Division of Informatics, Imaging, and Data Sciences (E.K.), School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), The University of Manchester, United Kingdom. 6. Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece (G.N.). 7. Division Heart and Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht University, the Netherlands (F.W.A.).
Abstract
BACKGROUND AND PURPOSE: Data about variations in stroke incidence and subsequent major adverse outcomes are essential to inform secondary prevention and prioritizing resources to those at the greatest risk of major adverse end points. We aimed to describe the age, sex, and socioeconomic differences in the rates of first nonfatal stroke and subsequent major adverse outcomes. METHODS: The cohort study used linked Clinical Practice Research Datalink and Hospital Episode Statistics data from the United Kingdom. The incidence rate (IR) ratio of first nonfatal stroke and subsequent major adverse outcomes (composite major adverse cardiovascular events, recurrent stroke, cardiovascular disease-related, and all-cause mortality) were calculated and presented by year, sex, age group, and socioeconomic status based on an individual's location of residence, in adults with incident nonfatal stroke diagnosis between 1998 and 2017. RESULTS: A total of 82 774 first nonfatal stroke events were recorded in either primary care or hospital data-an IR of 109.20 per 100 000 person-years (95% CI, 108.46-109.95). Incidence was significantly higher in women compared with men (IR ratio, 1.13 [95% CI, 1.12-1.15]; P<0.001). Rates adjusted for age and sex were higher in the lowest compared with the highest socioeconomic status group (IR ratio, 1.10 [95% CI, 1.08-1.13]; P<0.001). For subsequent major adverse outcomes, the overall incidence for major adverse cardiovascular event was 38.05 per 100 person-years (95% CI, 37.71-38.39) with a slightly higher incidence in women compared with men (38.42 versus 37.62; IR ratio, 1.02 [95% CI, 1.00-1.04]; P=0.0229). Age and socioeconomic status largely accounted for the observed higher incidence of adverse outcomes in women. CONCLUSIONS: In the United Kingdom, incidence of initial stroke and subsequent major adverse outcomes are higher in women, older populations, and people living in socially deprived areas.
BACKGROUND AND PURPOSE: Data about variations in stroke incidence and subsequent major adverse outcomes are essential to inform secondary prevention and prioritizing resources to those at the greatest risk of major adverse end points. We aimed to describe the age, sex, and socioeconomic differences in the rates of first nonfatal stroke and subsequent major adverse outcomes. METHODS: The cohort study used linked Clinical Practice Research Datalink and Hospital Episode Statistics data from the United Kingdom. The incidence rate (IR) ratio of first nonfatal stroke and subsequent major adverse outcomes (composite major adverse cardiovascular events, recurrent stroke, cardiovascular disease-related, and all-cause mortality) were calculated and presented by year, sex, age group, and socioeconomic status based on an individual's location of residence, in adults with incident nonfatal stroke diagnosis between 1998 and 2017. RESULTS: A total of 82 774 first nonfatal stroke events were recorded in either primary care or hospital data-an IR of 109.20 per 100 000 person-years (95% CI, 108.46-109.95). Incidence was significantly higher in women compared with men (IR ratio, 1.13 [95% CI, 1.12-1.15]; P<0.001). Rates adjusted for age and sex were higher in the lowest compared with the highest socioeconomic status group (IR ratio, 1.10 [95% CI, 1.08-1.13]; P<0.001). For subsequent major adverse outcomes, the overall incidence for major adverse cardiovascular event was 38.05 per 100 person-years (95% CI, 37.71-38.39) with a slightly higher incidence in women compared with men (38.42 versus 37.62; IR ratio, 1.02 [95% CI, 1.00-1.04]; P=0.0229). Age and socioeconomic status largely accounted for the observed higher incidence of adverse outcomes in women. CONCLUSIONS: In the United Kingdom, incidence of initial stroke and subsequent major adverse outcomes are higher in women, older populations, and people living in socially deprived areas.
Authors: Cother Hajat; Peter U Heuschmann; Catherine Coshall; Soundrie Padayachee; John Chambers; Anthony G Rudd; Charles D A Wolfe Journal: J Neurol Neurosurg Psychiatry Date: 2010-10-25 Impact factor: 10.154
Authors: Tim Doran; Catherine Fullwood; Hugh Gravelle; David Reeves; Evangelos Kontopantelis; Urara Hiroeh; Martin Roland Journal: N Engl J Med Date: 2006-07-27 Impact factor: 91.245
Authors: P M Rothwell; A J Coull; L E Silver; J F Fairhead; M F Giles; C E Lovelock; J N E Redgrave; L M Bull; S J V Welch; F C Cuthbertson; L E Binney; S A Gutnikov; P Anslow; A P Banning; D Mant; Z Mehta Journal: Lancet Date: 2005-11-19 Impact factor: 79.321
Authors: Johannes M I H Gho; Amand F Schmidt; Laura Pasea; Stefan Koudstaal; Mar Pujades-Rodriguez; Spiros Denaxas; Anoop D Shah; Riyaz S Patel; Chris P Gale; Arno W Hoes; John G Cleland; Harry Hemingway; Folkert W Asselbergs Journal: BMJ Open Date: 2018-03-03 Impact factor: 2.692
Authors: Valery L Feigin; Rita V Krishnamurthi; Priya Parmar; Bo Norrving; George A Mensah; Derrick A Bennett; Suzanne Barker-Collo; Andrew E Moran; Ralph L Sacco; Thomas Truelsen; Stephen Davis; Jeyaraj Durai Pandian; Mohsen Naghavi; Mohammad H Forouzanfar; Grant Nguyen; Catherine O Johnson; Theo Vos; Atte Meretoja; Christopher J L Murray; Gregory A Roth Journal: Neuroepidemiology Date: 2015-10-28 Impact factor: 3.282
Authors: Michelle H Leppert; James F Burke; Lynda D Lisabeth; Tracy E Madsen; Dawn O Kleindorfer; Stefan Sillau; Lee H Schwamm; Stacie L Daugherty; Cathy J Bradley; P Michael Ho; Sharon N Poisson Journal: Stroke Date: 2022-01-24 Impact factor: 7.914
Authors: Ralph K Akyea; Wolfram Doehner; Barbara Iyen; Stephen F Weng; Nadeem Qureshi; George Ntaios Journal: J Cachexia Sarcopenia Muscle Date: 2021-09-27 Impact factor: 12.910